NEW YORK, May 26, 2021 /PRNewswire/ -- MindMed (Nasdaq: MNMD) (NEO: MMED) (DE: MMQ), a leading psychedelic medicine biotech company, announced today the publication of the first pharmacogenetic data ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback